Analysis of pharmacokinetics and pharmacodynamics for capecitabine during new chemotherapy regimen by bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2628391
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Measurement ofcapecitabin metabolism during XELOX+BV 5-days on/ 2-days off schedule
Primary outcome(s): Confirmation for PK/PD analysis of capecitabine
Study Design: Single arm Non-randomized
创建时间：
2014-02-15
